Ligand Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Sep 23 | BuyUS$237,529 | Todd Davis | Individual | 4,000 | US$59.38 | |
16 May 23 | SellUS$343,081 | John Kozarich | Individual | 4,444 | US$77.20 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,848 | 0.0217% |
State or Government | 10,544 | 0.0594% |
Individual Insiders | 1,016,041 | 5.73% |
Institutions | 16,707,275 | 94.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,962,314 | US$207.0m | 4.27% | no data | |||
1,876,514 | US$131.1m | 1.33% | no data | |||
1,343,154 | US$93.9m | 0.1% | 0.04% | |||
987,354 | US$69.0m | -0.45% | 0.08% | |||
668,284 | US$46.7m | 7.22% | no data | |||
661,298 | US$46.2m | 7.63% | 0.01% | |||
659,434 | US$46.1m | 41% | 0.69% | |||
428,051 | US$29.9m | -2.31% | 2.69% | |||
417,695 | US$29.2m | 0% | no data | |||
370,815 | US$25.9m | 5.16% | no data | |||
325,727 | US$22.8m | 59.1% | 0.07% | |||
290,418 | US$20.3m | -9.28% | 0.02% | |||
276,008 | US$19.3m | -2.46% | 1.24% | |||
229,596 | US$16.0m | -0.83% | 0.54% | |||
227,662 | US$15.9m | 28.1% | 0.09% | |||
221,927 | US$15.5m | 7.52% | 0.74% | |||
219,780 | US$15.4m | -0.05% | no data | |||
205,208 | US$14.3m | 11.3% | 0.04% | |||
196,498 | US$13.7m | 15.6% | 0.02% | |||
194,754 | US$13.6m | -5.64% | 0.01% | |||
185,630 | US$13.0m | 36.5% | 0.01% | |||
162,187 | US$11.3m | 0% | no data | |||
161,480 | US$11.3m | 0% | no data | |||
154,072 | US$10.8m | 7.02% | no data | |||
143,752 | US$10.0m | -2.41% | 0.04% |